[February 11, 2014]

Research and Markets: Concise Analysis of Drug Solubility Technology: Spray Drying, Extrusion, and SCF

Research and Markets (http://www.researchandmarkets.com/research/lm7292/drug_solubility) has announced the addition of the "Concise Analysis of Drug Solubility Technology: Spray Drying, Extrusion, and SCF" report to their offering.

As drug suppliers re-examine their business models to adjust to the rapidly evolving competitive landscape, the importance and impact of drug solubility on drug design and development is increasing in importance, extending beyond potential future drug therapeutics, and affecting current reformulation strategies as well.

As large-molecule therapeutics increase in number and as a percentage of all drug discoveries, the economic scales will tip in favor of those drug developers possessing the ability to engineer water-soluble formulations of inherently hydrophobic compounds.

The importance of solubilization technologies is also underscored by the capabilitythey bestow on formulators attempting to re-formulate approved drugs approaching the end of their patent life. The survey examines established physical processes for improving and enhancing drug solubility, including spray dry dispersion, hot melt extrusion and supercritical fluid processing.

Highlights

• Analyzes and evaluates drug formulation process technology improving the properties of insoluble poorly soluble and/or poorly absorbed drug candidates
• Examines evolving market factors
• Provides detailed assessments and status of commercial technologies designed to improve drug solubility
• Profiles drug solubility technology market participants, their research activity, proprietary technology, and business strategies

Key Topics Covered:

Executive Summary

Drug Solubility Technology

Spray Dry Dispersion

Technology Market Drivers

Physicochemical Properties

Hot Melt Extrusion

Supercritical Fluid Processing

Approved Drug Products Formulated with SDD/HME/SFP

Acetaminophen

Nifedipine

Everolimus

Nabilone

Diethylpropion

Emend

Vildagliptin/Metformin

Clozapine

Fenofibrate

Griseofulvin

Ibuprofen

Etonogestrel

Etravirine

Verapamil

Liponavir+Ritonavir

Lacrisert

Tacrolimus

Rizatriptan

Naproxen

Norvir

Tapentadol

Etonogestrel, Ethinyl Estradiol

Itraconazole

Dexamethasone

Hydromorphone

Rapamune

Tricor, Triglide

Zoladex

Development/Pipeline Analysis and Assessment

Company Profiles

For more information visit http://www.researchandmarkets.com/research/lm7292/drug_solubility

[ Back To TMCnet.com's Homepage ]